Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus intra-cuff hydrocortisone for prevention of post-intubation sore throat, cough, and nausea
IRCT201603033064N3Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of hydrocortisone (2 arms), sponsored by Shahroud University of Medical Sciences. Primary endpoints: Severity of sore throat after tracheal intubation, Severity of cough after tracheal intubation and 1 more. Started Jan 2016; status: completed.
02
Drugs
hydrocortisone
Beyond the preview
Go deeper on IRCT201603033064N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201603033064N3.